Exhibit 10.1


    LICENSE
      AGREEMENT

    FOR
      SOFTWARE TOGETHER WITH ASSOCIATED, ISSUED AND PENDING PATENT 

    APPLICATIONS
      AND KNOW-HOW

     

    THIS
      AGREEMENT
      effective __________________, 2007 is entered into by and between the following
      parties:

    


    
      	
              Ralph
                Allan Wimmer (“RAW”)

              4783
                Woodley Drive

              West
                Vancouver, BC

              (Hereinafter
                RAW)

            	
              Bright
                Screens Inc. (“BSI”)

              10120
                S. Eastern Ave., Suite 200

              Henderson,
                NV

              USA
                89052

              A
                Nevada corporation

              (Hereinafter
                License)

            


    

    


    BACKGROUND

    


    WHEREAS,
      Ralph
      Allan Wimmer (“RAW”) possesses the patents (issued and pending) for the
Optical
      Channel Plates Technology, and which is defined in more detail
      below:

    


    WHEREAS,
      RAW
      is the
      owner of issued United States Letters Patent as follows:

    


    U.S.
      Patent US 6,928,219 was granted on August 9th,
      2005;

    


    U.K.
      GB
      2364791 was granted on December 29th,
      2004;
      and

    


    E.P.
      1325363 was granted on 8th
      November
      2006 - presently being 

    validated
      in Germany, France and Ireland. The German patent office has
      assigned

    the
      patent number DE 601 24 412.5-08 to the EP (DE) patent. The French
      and

    Irish
      patent offices will use the European Patent number.

    


    WHEAREAS,
      Bright
      Screens, Inc. (“BSI”), now wishes to become a Licensee of

    RAW
      in
      order to obtain, utilize and commercialize the Optical Channel Plates
      Technology.

    


    NOW,
      THEREFORE,
      in
      consideration of the terms and conditions and mutual promises contained herein,
      the parties agree as follows:

    


    2.
      DEFINITIONS

    


    The
      following capitalized terms are used herein with the following
      meanings:

    


    A. “Licensed
      Patents” refers to the issued U.S. Patents 6,928,219 and UK patents
      2364791, and to any and all U. S. Patents issuing from the Applications and
      any
      foreign patents corresponding to the Applications.

    


    B. “Applications”
      means the applications for any other jurisdiction which stem from the original
      GB Filing.

    


    C. “OCP
      Technology and Know-How” shall include the Licensed Patents, the Applications
      and any Know-How contained in the Deliverables or otherwise disclosed to
      Licensee by RAW.

    


    D. “OCP
      Technology” means making practical use of any of the inventions claimed in the
      Licensed Patents, the Applications or any of the OCP Technology or Know-How
      disclosed to Licensee by RAW.

    


    E. “Affiliate”
      means a fifty-one percent (51%) or more majority owned subsidiary of Licensee,
      but such subsidiary shall be deemed to be an Affiliate only so long as such
      ownership exists.

    


    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    


    I.
      GRANT OF LICENSE

    


    1.1 Technology
      License - Subject to the terms and conditions in this License Agreement, RAW
      hereby grants to Licensee and to Licensee’s Affiliates (but only for so long as
      any such Affiliate fulfils the definition above), the right and license with
      respect to the OCP, to create and prepare products for sale.

    


    1.2 The
      above
      right granted by RAW to the Project and now the Licensee and its Affiliates
      shall be exclusive.

    


    1.3 Licensee
      shall not have the right to sublicense the OCP Technology and Know-How to any
      third party.

    


    1.4 Licensee
      acknowledges and agrees that it is not entitled to participate in the
      prosecution of The Applications, and that it has no proprietary interest in
      the
      OCP Technology and Know-How except as a Licensee hereunder. Further, the parties
      agree that the continuing prosecution of The Applications and scope of any
      resulting patents shall be at RAW’s sole option. No license is granted to
      Licensee by RAW, either directly or by implication, estoppel or otherwise,
      under
      any patents including the Licensed Patents, except that the License of the
      OCP
      technology to Licensee shall be deemed not to infringe the RAW patents listed
      anywhere in the agreement.

    


    1.5 Know
      -
      How provisions

    


    Licensee
      shall treat all RAW Know-How as confidential information.

    


    II.
      PAYMENTS AND ROYALTIES

     

    Patent
      Royalties: For rights under any and all Licensed Patents, for a period of 20
      years from the date of this agreement, a royalty of Five Per Cent (5%) of gross
      sales of BSI.

    


    III.
      ACCOUNTING

    


    3.1 Accounting:
      Licensee agrees to maintain, in accordance with Generally Accepted Accounting
      Practices, and keep at its principal place of business in the United States,
      full and accurate records on all Licensed Product manufactured, shipped, used,
      sold or otherwise disposed of including without limitation by way of Commercial
      Sale.

    


    3.2 During
      the term of the License Agreement and for 12 months thereafter, Licensee agrees
      to allow an Independent Public Accountant(s) designated by RAW, and at RAW’s
      expense, during normal business hours and upon at least 48 hours notice, to
      examine and audit said records and any other material of Licensee that the
      Accountant shall deem necessary to determine the sales and net revenue of the
      Licensee. The Accountant shall report to RAW only whether Licensee’s reports
      have or have not been correct, and the amount of any error. All other
      information disclosed to the Accountant shall be maintained in strict
      confidence. Such audit shall take place no more than once per year, unless
      an
      error of greater than 5% of Licensee’s yearly revenues is found.

    


    3.3
       Licensee
      agrees to render to RAW within 60 days after the end of each Licensee’s business
      year full and accurate statements showing the amount of Licensed product
      shipped, or otherwise put to use by Licensee, during the proceeding quarterly
      business period.

    


    IV.
      DELIVERABLES

    


    RAW
      shall
      provide reasonable support to Licensee during the first six (6) months of this
      agreement regarding the OCP Technology and Know-How as implemented in the
      KCE.

    


    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    


    V.
      CONFIDENTIALITY

    


    5.1 Licensee
      agrees that it will hold in trust and will not disclose, distribute, copy,
      reproduce, reveal, publish or communicate to any person which is not an
      Affiliate, any of the OCP Technology and Know-How or other confidential or
      proprietary information of RAW.

    


    6.1 RAW
      represents that no claim of infringement of any copyright, patent, trade secret
      or other intellectual property right has been made or is pending against RAW
      relative to the OCP Technology and Know-How. Notwithstanding anything to the
      contrary contained herein, the parties agree that due to the specified royalty
      and to Licensee’s incorporation and change of the technology into Licensed
      Products. RAW shall have no obligation to indemnify License in regard to any
      allegation and/or finding of infringement of any patent, copyright, trade secret
      or other intellectual property right hereunder. RAW assumes no liability in
      respect of any infringement of any patents or other rights of third parties
      arising from the OCP Technology and Know-How and/or Licensed Patents. Further,
      nothing contained herein shall be construed as an obligation to bring or
      prosecute actions against third party infringers of the Licensed Patents and/or
      the OCP Technology and Know-How.

    


    6.2 Upon
      notice by RAW, Licensee agrees that it shall mark all OCP Products with the
      statement:  “Licensed
      under one or more of the following Patents: (patent numbers)”.

    


    VII.
      WARRANTY AND LIMITATION OR WARRANTY

    


    7.1 RAW
      warrants that it is the author of and has the full and exclusive right, title,
      and interest in and to the OCP Technology and Know-How and the technology known
      as the KCE.

    


    7.2 License
      acknowledges that RAW is making no warranty or representation as to the use,
      operation, fitness or salability of the Licensed Products.

    


    7.3 OTHER
      THAN AS SET FORTH HEREIN, THERE ARE NO OTHER WARRANTIES EITHER EXPRESS OR
      IMPLIED, INCLUDING WITHOUT LIMITATION THE WARRANTIES OF MERCHANTABILITY AND
      FITNESS FOR A PARTICULAR PURPOSE. THE OCP TECHNOLOGY IS DELIVERED TO LICENSEE
      “AS IS”. RAW SHALL NOT BE LIABLE FOR ANY DAMAGES INCURRED BY LICENSEE INCLUDING
      BUT NOT LIMITED TO GENERAL, SPECIAL, CONSEQUENTIAL OR INCIDENTAL DAMAGES ARISING
      FROM OR IN CONNECTION WITH THE DELIVERY, USE, OR PERFORMANCE OF THE OCP
      TECHNOLOGY AND KNOW-HOW AND/OR THE LICENSED PRODCUTS. THE PARTIES AGREE THAT
      LICENSEE SHALL BE SOLELY RESPONSIBLE FOR DETERMINING THE ACCEPTABILITY,
      FUNCTIONALITY, AND/OR THE USE OF THE OCP TECHNOLOGY AND KNOW-HOW IN LICENSED
      PRODUCTS.

    


    7.4 APART
      FROM DAMAGES ARISING FROM LICENSEE’S BREACH OF THE CONFIDENTIALITY OR
      INTELLECTUAL PROPERTY PROVISIONS OF THIS LICENSE AGREMENT, LICENSEE SHALL NOT
      BE
      LIABLE FOR ANY DAMAGES INCURRED BY RAW INCLUDING BUT NOT LIMITED TO GENERAL,
      SPECIAL, CONSEQUENTIAL OR INCIDENTAL DAMAGES ARISING FROM ON OR IN CONNECTION
      WITH LICENSEE’S MARKETING OR SALE OR LICENSED PRODUCT.

    


    VIII.
      TERM AND TERMINATION

    


    8.1 Except
      as
      otherwise provided herein, this License Agreement shall continue in full force
      in effect for a period of twenty years, or until the expiration date of the
      last
      Licensed Patents if later.

    


    8.2 If
      Licensee shall at any time default in making any payment required to be made
      by
      it under this License Agreement or shall fail to perform any of its obligations
      under this License Agreement, RAW, at its sole discretion, and in addition
      to
      any other remedies that it may have, at any time thereafter may terminate this
      agreement by giving at least thirty (30) days written notice to Licensee to
      terminate, which notice shall specify the breach relied upon. Licensee may
      prevent termination of this agreement by remedying said breach within the period
      of such notice.

    


    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    8.3 In
      the
      event this License Agreement is terminated for any reason, all licenses and
      rights granted Licensee hereunder shall cease and expire. No such termination,
      however, shall prejudice the rights of RAW to recover any royalty or other
      sum
      due at the time of such termination, nor prejudice any cause of action or claim
      of RAW accrued or to accrue on account of any breach or default hereunder by
      Licensee.

    


    IX.
      GOVERNING LAW

    


    9.1 Governing
      Law: This agreement is made in and shall be governed in all respects by the
      laws
      of the state of Nevada, USA. The parties agree that all negotiations,
      discussions, agreements between RAW and Core Relations Corp., have taken place
      in Nevada and no other jurisdiction, and both parties agree that no claim shall
      be made that the law of any other jurisdiction shall apply to this
      agreement.

    


    9.2 Both
      RAW
      and Licensee wish to avoid disputes relating to or arising out of this License
      Agreement. In the event of any dispute or perceived problem, each pledges itself
      to give notice to the other party and to seek an amicable resolution. Failure
      to
      reach agreement shall allow either party to reach resolution through Commercial
      Arbitration in Las Vegas, Nevada, USA.

    


    X.
      GENERAL PROVISIONS

    


    10.1 This
      License Agreement does not constitute a partnership agreement between the
      parties hereto.

    


    10.2 This
      License Agreement may not be changed except by written agreement signed by
      the
      parties hereto.

    


    10.3 Licensee
      shall be responsible for obtaining any an all export licenses, which may be
      required under this License Agreement.

    


    10.4 All
      notices required or permitted to be given hereunder shall be in writing and
      shall be sent by Certified or by Registered Mail, or by Federal Express courier
      or any other means of delivery of notice where an independent and verifiable
      record is kept by the transmitting service addressed as follows:

    


    To
      RAW:

    4783
      Woodley

    West
      Vancouver, BC

    Canada

    


    To
      Bright Screens, Inc.

    10120
      S.
      Eastern Avenue, Suite 2

    Henderson, NV 89052

    USA

    


    Either
      party shall give written notice to the other of any changes in its
      address.

    


    10.5 Any
      controversy between the parties with respect to any paragraph of this License
      Agreement, shall not affect the validity, operability, rights, or obligations
      of
      the parties under the remaining paragraphs of this License
      Agreement.

    


    10.6 This
      License Agreement (together with any Exhibits attached hereto) constitutes
      the
      entire agreement between the parties with respect to the subject matter hereof
      and shall supersede all prior agreements, oral or written, and all other
      communications between the parties relating to the subject matter
      hereof.

    


    In
      witness whereof, the parties hereto have executed this agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    


    AGREED
      BY:

     

    
      	RAW	
              Bright
                Screens, Inc. 

            
	 	 
	By:  /s/ Ralph A.
              Wimmer	
              By: 
                /s/ Carl Wimmer

            
	Title: Owner	Title:  President and Chief Executive
              Officer
	
              Date:
                April 5, 2007

            	
              Date: 
                April 5, 2007